Jiangsu Simcere Pharmaceutical Co., Ltd.
Records under this name other than the patents Jiangsu Simcere Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 2 of 2 · Back to Jiangsu Simcere Pharmaceutical Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,297,284 | Anti-TNFR2 antibody and use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,802,824 | Modified Recombinant Human Endostatin and Uses Thereof Lapsed on the fee record Ended Aug 12, 2026 · High confidence | Lapsed on the fee record | Ended Aug 12, 2026 | High confidence |